|
1
|
Zhang D and Fan D: New insights into the
mechanisms of gastric cancer multidrug resistance and future
perspectives. Future Oncol. 6:527–537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Santoro R, Carboni F, Lepiane P, Ettorre
GM and Santoro E: Clinicopathological features and prognosis of
gastric cancer in young European adults. Br J Surg. 94:737–742.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu T, Dhanasekaran SM, Jin H, Hu B,
Tomlins SA, Chinnaiyan AM and Phan SH: FIZZ1 stimulation of
myofibroblast differentiation. Am J Pathol. 164:1315–1326. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holcomb IN, Kabakoff RC, Chan B, Baker TW,
Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, et
al: FIZZ1, a novel cysteine-rich secreted protein associated with
pulmonary inflammation, defines a new gene family. EMBO J.
19:4046–4055. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raes G, De Baetselier P, Noël W, Beschin
A, Brombacher F and Hassanzadeh Gh G: Differential expression of
FIZZ1 and ym1 in alternatively versus classically activated
macrophages. J Leukoc Biol. 71:597–602. 2002.PubMed/NCBI
|
|
7
|
Stütz AM, Pickart LA, Trifilieff A,
Baumruker T, Prieschl-Strassmayr E and Woisetschläger M: The Th2
cell cytokines IL-4 and IL-13 regulate found in inflammatory zone
1/resistin-like molecule alpha gene expression by a STAT6 and
CCAAT/enhancer-binding protein-dependent mechanism. J Immunol.
170:1789–1796. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong L, Wang SJ, Camoretti-Mercado B, Li
HJ, Chen M and Bi WX: FIZZ1 plays a crucial role in early stage
airway remodeling of OVA-induced asthma. J Asthma. 45:648–653.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Filbey KJ, Grainger JR, Smith KA, Boon L,
van Rooijen N, Harcus y, Jenkins S, Hewitson JP and Maizels RM:
Innate and adaptive type 2 immune cell responses in genetically
controlled resistance to intestinal helminth infection. Immunol
Cell Biol. 92:436–448. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Angelini DJ, Su Q, Kolosova IA, Fan C,
Skinner JT, Yamaji-Kegan K, Collector M, Sharkis SJ and Johns RA:
Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELM alpha) recruits
bone marrow-derived cells to the murine pulmonary vasculature. PLoS
One. 5:e112512010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weidner N, Folkman J, Pozza F, Bevilacqua
P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis:
A new significant and independent prognostic indicator in
early-stage breast carcinoma. J Natl Cancer Inst. 84:1875–1887.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang L, Ma J, Tang Y, Chen P, Zhang S,
Zhang Y and Yuan YZ: siRNA-based targeting of fractalkine
overexpression suppresses inflammation development in a severe
acute pancreatitis rat model. Int J Mol Med. 30:514–520.
2012.PubMed/NCBI
|
|
13
|
Steppan CM and Lazar MA: The current
biology of resistin. J Intern Med. 255:439–447. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun Y, Wang J, Li H and Han X: Found in
inflammatory zone 1 induces angiogenesis in murine models of
asthma. Lung. 186:375–380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Yang Y, Fang J and Zhang H: FIZZ1
could enhance the angiogenic ability of rat aortic endothelial
cells. Int J Clin Exp Pathol. 6:1847–1853. 2013.PubMed/NCBI
|
|
16
|
Osborne LC, Joyce KL, Alenghat T,
Sonnenberg GF, Giacomin PR, Du Y, Bergstrom KS, Vallance BA and
Nair MG: Resistin-like molecule α promotes pathogenic Th17 cell
responses and bacterial-induced intestinal inflammation. J Immunol.
190:2292–2300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamaji-Kegan K, Su Q, Angelini DJ,
Champion HC and Johns RA: Hypoxia-induced mitogenic factor has
proangiogenic and proinflammatory effects in the lung via VEGF and
VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol.
291:L1159–L1168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Munitz A, Waddell A, Seidu L, Cole ET,
Ahrens R, Hogan SP and Rothenberg ME: Resistin-like molecule alpha
enhances myeloid cell activation and promotes colitis. J Allergy
Clin Immunol. 122:1200.e1–1207.e1. 2008. View Article : Google Scholar
|
|
19
|
Munitz A, Seidu L, Cole ET, Ahrens R,
Hogan SP and Rothenberg ME: Resistin-like molecule alpha decreases
glucose tolerance during intestinal inflammation. J Immunol.
182:2357–2363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suzuki S, Dobashi Y, Hatakeyama Y, Tajiri
R, Fujimura T, Heldin CH and Ooi A: Clinicopathological
significance of platelet-derived growth factor (PDGF)-B and
vascular endothelial growth factor-A expression, PDGF receptor-β
phosphorylation, and microvessel density in gastric cancer. BMC
Cancer. 10:6592010. View Article : Google Scholar
|
|
21
|
Sia D, Alsinet C, Newell P and Villanueva
A: VEGF signaling in cancer treatment. Curr Pharm Des.
20:2834–2842. 2014. View Article : Google Scholar
|
|
22
|
Abid MR, Schoots IG, Spokes KC, Wu SQ,
Mawhinney C and Aird WC: Vascular endothelial growth
factor-mediated induction of manganese superoxide dismutase occurs
through redox-dependent regulation of forkhead and
IkappaB/NF-kappaB. J Biol Chem. 279:44030–44038. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu YF, Zhang Y, Shen N, Zhang RY and Lu
XQ: Effect of VEGF, P53 and telomerase on angiogenesis of gastric
carcinoma tissue. Asian Pac J Trop Med. 7:293–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vermeulen PB, Gasparini G, Fox SB, Toi M,
Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL,
et al: Quantification of angiogenesis in solid human tumours: An
international consensus on the methodology and criteria of
evaluation. Eur J Cancer. 32A:2474–2484. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin Y, Si X, Gao Y, Gao L and Wang J: The
nuclear factor-κB correlates with increased expression of
interleukin-6 and promotes progression of gastric carcinoma. Oncol
Rep. 29:34–38. 2013.
|
|
28
|
Teng X, Li D, Champion HC and Johns RA:
FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung
with vasoconstrictive and angiogenic properties. Circ Res.
92:1065–1067. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tong Q, Zheng L, Lin L, Li B, Wang D,
Huang C and Li D: VEGF is upregulated by hypoxia-induced mitogenic
factor via the PI-3K/Akt-NF-kappaB signaling pathway. Respir Res.
7:372006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan C, Wang H, Aggarwal B and Boyd DD: A
novel homologous recombination system to study 92 kDa type IV
collagenase transcription demonstrates that the NF-kappaB motif
drives the transition from a repressed to an activated state of
gene expression. FASEB J. 18:540–541. 2004.PubMed/NCBI
|
|
31
|
Bergers G, Brekken R, McMahon G, Vu TH,
Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, et al:
Matrix metallo-proteinase-9 triggers the angiogenic switch during
carcinogenesis. Nat Cell Biol. 2:737–744. 2000. View Article : Google Scholar : PubMed/NCBI
|
